Partner-Funded 1,500 Metre Drill Program Underway at Cerro Bayo and Launch of Copper-Gold Spin-Out Latin Explore to Be Featured at PDAC 2026VANCOUVER, British Columbia, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Latin Metals Inc. ("Latin Metals" or the "Company") (TSXV: LMS) (OTCQB: LMSQF) is pleased to invite current and prospective investors to meet with management at the Prospectors & Developers Association of Canada (PDAC) Convention 2026, the foremost global mining and mineral exploration conference. The PDAC C ...

Company Overview - Genmab A/S is an international biotechnology company focused on improving the lives of patients through innovative antibody therapeutics [2] - Established in 1999, Genmab is headquartered in Copenhagen, Denmark, with a presence in North America, Europe, and Asia Pacific [3] Upcoming Events - Members of Genmab's Executive Committee will participate in investor conferences in March 2026, including: - TD Cowen 46 Annual Healthcare Conference in Boston on March 3, 2026, at 9:10 AM EST - Leerink Global Healthcare Conference in Miami on March 10, 2026, at 8:40 AM EDT - Barclays 28 Annual Global Healthcare Conference in Miami on March 11, 2026, at 1:30 PM EDT [6] Strategic Vision - By 2030, Genmab aims to transform the lives of individuals with cancer and other serious diseases through its proprietary pipeline of next-generation antibody medicines, referred to as "knock-your-socks-off" (KYSO) antibody medicines [2]

Core Insights - XBP Global Holdings, Inc. is recognized for its leadership in workflow automation, particularly through AI-driven document processing, which is deemed essential for public-sector automation [1][4] - The company emphasizes the integration of AI within governed operating environments to enhance operational efficiency and accountability [2][5] Group 1: Company Strategy and Technology - XBP Global's strategy focuses on combining intelligent automation with disciplined execution, positioning itself as a leader in the evolving landscape of AI adoption [2][5] - The company has developed an Intelligent Document Processing (IDP) platform that automates high-volume, document-intensive operations, ensuring security and compliance [4][5] Group 2: Real-World Applications - The company has implemented AI-led document processing in critical operations, such as its collaboration with HM Passport Office, which requires high accuracy and regulatory compliance [3][4] - XBP Global's approach includes a structured human-in-the-loop model, where trained specialists manage validation and oversight, enhancing the reliability of AI applications [3][4] Group 3: Market Position and Client Base - XBP Global operates in 20 countries with approximately 11,000 employees and serves over 2,500 clients, including many Fortune 100 companies [8] - The company aims to facilitate hyper-automation for organizations, leveraging its proprietary platforms and deep domain expertise across various sectors [9]

SANTA MONICA, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- JAKKS Pacific, Inc. (NASDAQ: JAKK), a leading global manufacturer of toys and consumer products, today announced an exciting new partnership with Crunchyroll, the global brand fueling anime fandom, to design, manufacture, market, and sell an all-new extensive line of toys, cosplay, and collectibles based on popular anime properties from Crunchyroll’s library. Under the agreement, JAKKS will become one of the major US manufacturers to bring official Cru ...

Core Viewpoint - Labrador Gold Corp. successfully held its Annual General and Special Meeting of Shareholders, where shareholders overwhelmingly supported the Corporation's recommendations, including the election of directors and approval of key resolutions [1][2]. Shareholder Meeting Results - A total of 83,756,898 Common Shares, representing 49.27% of the issued shares, were represented at the Meeting [2]. - The Corporation's director nominees were elected with an average of 97.39% votes cast 'FOR' [2]. - The voting results for the director nominees are as follows: - James Borland: 97.976% votes 'FOR' [2] - Leo Karabelas: 97.140% votes 'FOR' [2] - Roger Moss: 96.369% votes 'FOR' [2] - Kevin Ramsay: 98.102% votes 'FOR' [2] - Other resolutions passed include: - Stock Option Plan: 95.515% votes 'FOR' [2] - Change of Business: 71.747% votes 'FOR' [2] - Change of Name: 69.511% votes 'FOR' [2] - Dissident resolutions did not pass, with the Director Removal Resolution receiving only 28.195% votes 'FOR' [2]. Company Overview - Labrador Gold Corp. is a Canadian mineral exploration company focused on acquiring and exploring gold projects in Eastern Canada [5]. - The Watson Project, a joint venture with Nemo Resources Inc., is noted as the largest landholding in the Fort Hope Greenstone Belt, which is underexplored compared to other belts in northwestern Ontario [6]. - The Hopedale property covers much of the Florence Lake greenstone belt, with identified gold anomalies and potential for copper, nickel, and cobalt [7]. - The Borden Lake project is located near Discovery Silver Corp's Borden gold mine, with past exploration identifying two anomalous gold zones [8].

Core Insights - Boralex Inc. will release its fourth quarter results for 2025 on February 27, 2026, at 11 a.m. ET, with a conference call for financial analysts and investors [1][2] Group 1: Financial Results Announcement - The financial results will be presented during a conference call, and interested parties can attend via a webcast or phone registration [2][3] - A press release with financial information will be available on Boralex's website on February 27, 2026, at 7 a.m. [3] Group 2: Company Overview - Boralex has been a leader in providing affordable renewable energy for over 35 years, with a significant presence in Canada and France as the largest independent producer of onshore wind power [4] - The company's installed capacity has increased by over 50% in the past five years, reaching 3,403 MW as of now, following the commissioning of a new 100 MW wind farm [4] - Boralex is developing a portfolio of projects totaling 8 GW in wind, solar, and storage, emphasizing corporate social responsibility and sustainability [4]

Core Viewpoint - nVent Electric plc has rescheduled its 2026 Investor Day to March 18, 2026, due to a state of emergency in the New York City metropolitan area caused by a major winter storm [1] Group 1: Event Details - The updated Investor Day will feature presentations from Beth Wozniak, nVent chair and CEO, along with senior leadership discussing updated medium-term financial objectives and the next phase of the company's growth strategy [2] - The event will take place from 9:30 a.m. ET to approximately 12:00 p.m. ET, with live and on-demand webcasts available through the investor relations section of the company's website [3] - A refreshed invitation and registration details for in-person attendance will be issued separately [3] Group 2: Company Overview - nVent is a leading global provider of electrical connection and protection solutions, focusing on enabling safer systems and ensuring a more secure world [4] - The company designs, manufactures, markets, installs, and services high-performance products that connect and protect sensitive equipment, buildings, and critical processes [4] - nVent's portfolio includes well-known brands such as nVent CADDY, ERICO, HOFFMAN, ILSCO, SCHROFF, and TRACHTE, with a history spanning over 100 years [5]

Core Insights - Precipio, Inc. has reported strong preliminary financial results for Q4-2025 and fiscal year 2025, highlighting significant growth in revenue and positive cash flow metrics [1][5]. Financial Performance - Revenue Growth: Precipio's revenues increased from $18.5 million in 2024 to $24.0 million in 2025, representing a 30% year-over-year increase. Q4-2025 revenues were $6.7 million, up 23% from $5.4 million in Q4-2024 [5]. - Positive Adjusted EBITDA: The company will report Adjusted EBITDA of $0.95 million for Q4-2025 and $1.23 million for the full year 2025, compared to $0.40 million in Q4-2024 and a loss of $1.5 million for the full year 2024 [5]. - Positive Operating Cash Flow: Precipio will report $368,000 of positive operating cash flow during Q4-2025 and a total of $688,000 for 2025, compared to $439,000 generated from operations in 2024 [5]. Management Commentary - The CEO, Ilan Danieli, emphasized the importance of becoming an EBITDA and cash-flow positive business, allowing for investments in long-term growth projects rather than focusing solely on short-term cash burn [2]. The company experienced a strong performance in 2025, with shareholders seeing their value triple [2]. Company Overview - Precipio is a healthcare biotechnology company focused on cancer diagnostics, aiming to address cancer misdiagnoses through innovative diagnostic products and services that enhance accuracy and improve patient outcomes [6].

Core Viewpoint - Brunswick Exploration Inc. is initiating a non-brokered private placement to raise up to $4 million through the sale of 16 million units at a price of $0.25 per unit, aimed at expanding its lithium exploration efforts in Saudi Arabia and other regions [1][2]. Financing Details - The offering consists of units, each comprising one common share and one half of a common share purchase warrant, with warrants allowing the purchase of shares at $0.35 for 36 months post-closing [2]. - The offering is expected to close around March 18, 2026, subject to necessary approvals [6]. Use of Proceeds - The net proceeds from the offering will be allocated for exploration activities in Canada, Saudi Arabia, and Greenland, as well as for general corporate purposes and working capital [4]. Insider Participation - Participation by insiders in the offering will be classified as a related party transaction, with the company relying on exemptions from formal valuation and minority shareholder requirements [5]. Company Overview - Brunswick Exploration is focused on grassroots lithium exploration in Canada, Greenland, and Saudi Arabia, with a significant property portfolio underpinned by its Mirage project, which has an inferred mineral resource estimate of 52.2 million tonnes grading 1.08% Li2O [9][10].

Incannex’s common stock is expected to begin trading on a post-split adjusted basis on February 27, 2026MELBOURNE, Australia and NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) (“Incannex” or the “Company”), a clinical-stage pharmaceutical company developing innovative combination therapies for high-impact medical conditions, today announced that the board of directors of the Company approved a 1-for-30 reverse stock split (the “Reverse Split”) of the Company’s common sto ...